Full text 
Procedure : 2020/0321(COD)
Document stages in plenary
Document selected : A9-0216/2021

Texts tabled :


Debates :

PV 07/07/2021 - 13
PV 07/07/2021 - 15
CRE 07/07/2021 - 13
CRE 07/07/2021 - 15

Votes :

PV 08/07/2021 - 4
PV 08/07/2021 - 11
CRE 08/07/2021 - 4
PV 20/01/2022 - 3
CRE 20/01/2022 - 3

Texts adopted :


XML 5k
Wednesday, 7 July 2021 - Strasbourg

15. European Medicines Agency ***I (continuation of debate)

Report on the proposal for a regulation of the European Parliament and of the Council on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices [COM(2020)0725 - C9-0365/2020 - 2020/0321(COD)] - Committee on the Environment, Public Health and Food Safety. Rapporteur: Nicolás González Casares (A9-0216/2021)

(Start of debate: minutes of 7.7.2021, item 13)

The following spoke: Tilly Metz, on behalf of the Verts/ALE Group, Silvia Sardone, on behalf of the ID Group, Joanna Kopcińska, on behalf of the ECR Group, Kateřina Konečná, on behalf of The Left Group, Lefteris Nikolaou-Alavanos, non-attached Member, Peter Liese, Jytte Guteland, Véronique Trillet-Lenoir, Jutta Paulus, Ivan David, Margarita de la Pisa Carrión, Ivan Vilibor Sinčić, Bartosz Arłukowicz, Ivo Hristov, Mikuláš Peksa, Edina Tóth, Nathalie Colin-Oesterlé, Sara Cerdas, Mislav Kolakušić, Lídia Pereira and Alessandra Moretti.

The following spoke: Stella Kyriakides (Member of the Commission).

The debate closed.

Vote: minutes of 7.7.2021, item 20 (amendments); minutes of 8.7.2021, item 6 (final vote).

Announcement of voting results: minutes of 8.7.2021, item 4 (amendments); minutes of 8.7.2021, item 11 (final vote).

Last updated: 25 November 2021Legal notice - Privacy policy